¿¬°£Á¤º¸ ¼­ºñ½º
»óǰÄÚµå
960920

¹Ì±¹ÀÇ ³ì³»Àå ½ÃÀå : ºÐ±âº° ¾÷µ¥ÀÌÆ®

US Glaucoma Quarterly Update, Q4 - 2022: Analysis of Historical Trends and Latest Developments

¹ßÇàÁ¤º¸: | ¸®¼­Ä¡»ç: Market Scope, LLC | ÆäÀÌÁö Á¤º¸: ¿µ¹®

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

³ì³»Àå(Glaucoma) ¼ö¼ú ½ÃÀå¿¡ ´ëÇØ ºÐ±âº°·Î ¹Ì±¹ÀÇ ³ì³»Àå ¿Ü°úÀǸ¦ ´ë»óÀ¸·Î Á¶»ç¸¦ ½Ç½ÃÇÏ°í µ¥ÀÌÅ͸¦ ¼öÁýÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú¸¦ ºÐ¼®ÇßÀ¸¸ç, ºÐ±âº°·Î ¹Ý¿µµÇ´Â º¸°í¼­´Â ÇöÀç ½ÃÀå »óȲÀ» Á¤È®ÇÏ°Ô Æò°¡¡¤ÆÄ¾ÇÇÒ ¼ö ÀÖ¾î ÀÇ»ç°áÁ¤ ÇÁ·Î¼¼½º °³¼±À» ¸ñÀûÀ¸·Î Çϰí, ÀÇ·á ÇöÀåÀÇ Áß¿äÇÑ °úÁ¦, Àǻ翡 ÀÇÇÑ ÀǾàǰ¡¤¼ö¼ú ±â±¸ Æò°¡, Á¦Ç° »ç¿ë°ú ½ÃÀå Á¡À¯À², Á¦Ç° ä¿ë °èȹ, ³ì³»Àå Ä¡·á ½ÃÀåÀÇ Áß¿äÇÑ µ¿Çâ ÆÄ¾Ç µîÀ» Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

°¢ °»½Å¿¡´Â ¿¬Áß ¿¹Ãø, Àü³âµµ¿ÍÀÇ ºñ±³, µ¿Ç⠺м®ÀÌ Æ÷ÇԵ˴ϴÙ.

¿¬ 4ȸ, ¹Ì±¹ ³ì³»Àå ½ÃÀåÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ÃøÁ¤¡¤ºÐ¼®Çϰí ÀÖ½À´Ï´Ù.

  • ³ì³»Àå Ä¡·á¹ý
  • ÃÖ¼Òħ½À ³ì³»Àå ¼ö¼ú(MIGS)
  • ȯÀÚ º¹¾à »óȲ
  • º¹¾à ÄÄÇöóÀ̾ð½º
  • ³ì³»Àå Æ©ºê ¼ÇÆ®
  • ³ì³»Àå ¹è¾× ±â±â
  • ±âŸ ³ì³»Àå¿ë ±â±â¿Í Ä¡·á¹ý
  • ·¹ÀÌÀú ¼¶À¯ÁÖ¼ºÇü¼ú
  • ³ì³»Àå ÀÓ»ó½ÃÇè¾à¿¡ ´ëÇÑ °ü½Éµµ
KSM 20.10.21

Our coverage of the US glaucoma surgery market includes a quarterly surveying process that targets and collects data from glaucoma surgeons. The resulting data are analyzed and presented in our US Glaucoma Surgery Quarterly Updates. These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including a variety of vital practice of medicine issues, doctors' evaluations of pharmaceuticals and surgical equipment, product use and market share, product adoption plans, and the identification of significant trends in the marketplace for the treatment of glaucoma.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

The "US Glaucoma Quartrly Updates" measure and analyze key metrics of the US glaucoma market, including:

  • Primary patient diagnoses
  • Glaucoma treatment regimens: medication and surgical intervention rates
  • Number of prescribed medications
  • Patient medication usage and compliance
  • First line therapies
  • Glaucoma procedure volumes and share by type
  • MIGS procedures by product
  • MIGS adoption plans
  • Canal-based procedures by product
  • Glaucoma tube shunt procedure by product
  • Glaucoma drainage device procedures by product
  • Laser procedures by type
  • Other glaucoma devices and treatments
  • Interest level in investigational glaucoma treatments
  • Surgical locations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦